कृपया अन्य खोज का प्रयास करें
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michael J. Brownstein | - | - | Member of Scientific Board |
Christopher Redman | - | - | Member of Scientific Board |
Johannes Hulthe | 51 | 2019 | Independent Director |
Anthony James Kettle | - | - | Member of Scientific Board |
Johan Bygge | 65 | 2021 | Independent Chairman of the board |
Goran Forsberg | 58 | 2019 | Independent Director |
József Balla | - | - | Member of Scientific Board |
Gunvor Ekman Ordeberg | - | - | Member of Scientific Board |
Henning Schneider | - | - | Member of Scientific Board |
Lars Hockenstrom | 65 | 2019 | Independent Director |
Fredrik Lehmann | 47 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है